N. Choi

发表

Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion.

George T. Y. Chen, E. Rietzel, C. Willet, 2005, International journal of radiation oncology, biology, physics.

Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer.

Andrzej Niemierko, Abhijit A Patel, Abhijit A. Patel, 2009, International journal of radiation oncology, biology, physics.

Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations

Steve B. Jiang, Steve B Jiang, Stella Flampouri, 2006, Physics in medicine and biology.

The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?

L M Hamberg, N. Alpert, A. Fischman, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Simplified measurement of deoxyglucose utilization rate.

L M Hamberg, N. Alpert, A. Fischman, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics

Rakesh K Jain, R. Jain, Y. Boucher, 2002, Science.

Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.

G. Sharp, N. Choi, N. Shusharina, 2014, International journal of radiation oncology, biology, physics.

Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation.

N. Holalkere, A. Fischman, M. Blake, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.

Hak Choy, Jeffrey Bradley, Kyounghwa Bae, 2009, International journal of radiation oncology, biology, physics.

Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.

P. Jänne, Bruce E. Johnson, D. Sugarbaker, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.

S. Digumarthy, A. Iafrate, C. Channick, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

J. Meyerhardt, R. Bueno, N. Choi, 2016, BMC Cancer.

Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study.

N. Choi, J. Wain, T. Lynch, 1997, The Journal of thoracic and cardiovascular surgery.

A pilot study of neoadjuvant chemotherapy with 5‐fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagus

N. Choi, J. Wain, D. Mathisen, 1991, Cancer.

Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.

Joe Y. Chang, A. Lomax, C. Simone, 2016, International journal of radiation oncology, biology, physics.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-2004. A 56-year-old woman with cough and a lung nodule.

N. Choi, T. Lynch, E. Mark, 2004, The New England journal of medicine.

Biological target volume (BTV) determined with dose response data from the correlation between metabolic rate of glucose (MRG) measured with 18F-FDG PET and pathologic complete response (PCR) in stage III non-small cell lung cancer (NSCLC)

A. Fischman, A. Niemierko, N. Choi, 2000 .

Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction.

N. Choi, J. Wain, D. Mathisen, 1994, The Annals of thoracic surgery.

Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2018, International journal of radiation oncology, biology, physics.

Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus.

N. Choi, J. Wain, T. Lynch, 2002, The Annals of thoracic surgery.

Long-term outcomes of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017 .

POINT: Operative risk of pneumonectomy--influence of preoperative induction therapy.

N. Choi, J. Wain, D. Mathisen, 2009, The Journal of thoracic and cardiovascular surgery.

Case records of the Massachusetts General Hospital. Case 16-2007. A 61-year-old man with a mediastinal mass.

N. Choi, P. Fidias, J. Shepard, 2007, The New England journal of medicine.

Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update.

N. Choi, R. Carey, Robert W. Carey, 1989, International journal of radiation oncology, biology, physics.

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.

N. Choi, J. Herndon, J. Rosenman, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.

N. Choi, D. Mathisen, J. Herndon, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma.

N. Choi, J. Scannell, E. W. Wilkins, 1980, International journal of radiation oncology, biology, physics.

Small cell carcinoma of the lung. A progress report of 15 years' experience

N. Choi, J. Younger, R. Carey, 1987, Cancer.

Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors.

N. Choi, P. Fidias, J. Wain, 2008, The Annals of thoracic surgery.

A phase I study of carboplatin (Car) and docetaxel (Doc) followed by weekly Car/Doc with concurrent radiotherapy (CT/RT) in patients (pts) with stage III non-small cell lung cancer (NSCLC)

D. Sugarbaker, R. Herbst, N. Choi, 2000 .

Effect of postoperative radiotherapy on changes in pulmonary function in patients with stage II and IIIA lung carcinoma.

N. Choi, D. Kanarek, H. Grillo, 1990, International journal of radiation oncology, biology, physics.

A single‐nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy

A. Niemierko, R. Mak, D. Christiani, 2012, Cancer.

Controversies in the role of postoperative radiotherapy in stages II and IIIA resected non-small cell lung carcinoma.

N. Choi, 1991, International journal of radiation oncology, biology, physics.

Radiation therapy alone or in combination with surgery in the treatment of carcinoma of the esophagus

M. Langer, N. Choi, E. W. Wilkins, 1986, Cancer.

Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.

T. McLoud, A. Fischman, N. Choi, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Reassessment of the role of postoperative radiation therapy in resected lung cancer.

N. Choi, 1982, International journal of radiation oncology, biology, physics.

Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancer.

D. Rattner, J. Meyerhardt, R. Bueno, 2013, The oncologist.

Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus.

N. Choi, J. Wain, D. Mathisen, 1993, Cancer investigation.

Accelerated radiation therapy in small cell lung cancer: rationale and limitation in its utility.

N. Choi, 1990, International journal of radiation oncology, biology, physics.

A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: a Cancer and Leukemia Group B Study.

N. Choi, D. Kwiatkowski, K. Propert, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction treatment for resectable non-small-cell lung cancer.

N. Choi, F. Shepherd, J. Deslauriers, 1997, Lung cancer.

Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus.

N. Choi, D. Mathisen, R. Carey, 1988, The Annals of thoracic surgery.

Preoperative chemotherapy followed by surgery with possible postoperative radiotherapy in squamous cell carcinoma of the esophagus: evaluation of the chemotherapy component.

N. Choi, D. Mathisen, R. Carey, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thoracic radiation therapy in locally advanced NSCLC patients (pts) with EGFR mutations.

R. Mak, L. Sequist, N. Choi, 2010 .

Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In reply to Saraiya et al.

G. Sharp, N. Choi, N. Shusharina, 2014, International journal of radiation oncology, biology, physics.

Phase II cisplatin, irinotecan, cetuximab and concurrent radiation therapy followed by surgery for locally advanced esophageal cancer.

N. Choi, C. Fuchs, P. Enzinger, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Potential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer

A. Fischman, A. Niemierko, N. Choi, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Role of FLT PET in Supplementing FDG PET for Robust Classification of Metabolic Response Even in the Presence of Coexisting Pneumonitis in Radiotherapy or Chemoradiotherapy for Lung Cancer

A. Fischman, A. Niemierko, N. Choi, 2011 .

Improved quality of life of patients with small-cell carcinoma of the lung by elective irradiation of the brain.

N. Choi, J. Rosenman, 1982, International journal of radiation oncology, biology, physics.

IMRT Versus Passively Scattered Proton Therapy (PSPT) for Locally Advanced NSCLC -- Impact of Changing Techniques and Technologies Over the Course of a Randomized Trial

R. Mohan, R. Komaki, Z. Liao, 2012 .

Brain as a Major Site of Failure in Lung Cancer: How Effective is Cranial Irradiation?

N. Choi, 1986 .

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.

Radhe Mohan, Stephen M Hahn, John V Heymach, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial.

A. Marx, A. Bezjak, N. Choi, 2014, The Journal of thoracic and cardiovascular surgery.

Low dose fractionated whole body irradiation in the treatment of advanced non‐Hodgkin's lymphoma

N. Choi, R. Carey, A. Aisenberg, 1979, Cancer.

Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.

N. Choi, J. Wain, T. Lynch, 2004, International journal of radiation oncology, biology, physics.

Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism.

A. Fischman, R. Jain, N. Choi, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer.

N. Choi, J. Wain, D. Mathisen, 1996, The Journal of thoracic and cardiovascular surgery.

Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study.

N. Harris, N. Choi, J. Wain, 2000, International journal of radiation oncology, biology, physics.

Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases.

A. Niemierko, L. Sequist, H. Shih, 2015, Neuro-oncology.

Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC.

R. Mak, J. Neal, L. Sequist, 2011, The oncologist.

Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.

S. Digumarthy, R. Mak, L. Sequist, 2011, The oncologist.

Radiation therapy for postoperative local-regionally recurrent lung cancer.

N. Choi, G. Kopelson, 1980, International journal of radiation oncology, biology, physics.

Intradural spinal metastases in patients with posterior fossa brain metastases from various primary cancers.

R. Mirimanoff, N. Choi, 1987, Oncology.

The risk of intradural spinal metastases in patients with brain metastases from bronchogenic carcinomas.

R. Mirimanoff, N. Choi, 1986, International journal of radiation oncology, biology, physics.

Toxicity of thoracic radiotherapy on pulmonary function in lung cancer.

N. Choi, D. Kanarek, Noah C. Choi, 1994, Lung cancer.

DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer.

A. Niemierko, R. Mak, N. Choi, 2010, International journal of radiation oncology, biology, physics.

Maximum-intensity volumes for fast contouring of lung tumors including respiratory motion in 4DCT planning.

Eike Rietzel, Noah C. Choi, George T. Y. Chen, 2008, International journal of radiation oncology, biology, physics.

Recent progress in optimizing radiotherapy in chemo-radiotherapy for stage III non-small cell lung cancer

N. Choi, R. Rosell, 2002, Revista de Oncología.

Predictive factors in radiotherapy for non-small cell lung cancer: present status.

N Zamboglou, S Senan, N. Choi, 2001, Lung cancer.

Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase II study of Cancer and Leukemia Group B.

N. Choi, K. Propert, W. Eaton, 1987, International journal of radiation oncology, biology, physics.

Differences in lung injury after IMRT or proton therapy assessed by 18FDG PET imaging.

T. Bortfeld, R. Mohan, A. Niemierko, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer.

N. Choi, C. Willett, P. Fidias, 2006, International journal of radiation oncology, biology, physics.

Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.

R. Mohan, Z. Liao, N. Choi, 2019, International journal of radiation oncology, biology, physics.

Quantitative assessment of range fluctuations in charged particle lung irradiation.

Shinichiro Mori, John Wolfgang, Hsiao-Ming Lu, 2008, International journal of radiation oncology, biology, physics.

Superior sulcus lung tumors: impact of local control on survival.

N. Choi, J. Wain, D. Mathisen, 1999, The Journal of thoracic and cardiovascular surgery.

Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer.

Steve B. Jiang, Steve B Jiang, Helen A Shih, 2004, International journal of radiation oncology, biology, physics.

Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer.

A. Fischman, A. Niemierko, N. Choi, 2002, International journal of radiation oncology, biology, physics.

Improved survival of patients with unresectable non‐small‐cell bronchogenic carcinoma by an innovated high‐dose En‐Bloc radiotherapeutic approach

N. Choi, N C Choi, J A Doucette, 1981, Cancer.

Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation.

N. Choi, P. Sluss, T. Hong, 2008, Lung cancer.

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.

N. Choi, J. Wain, D. Mathisen, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does prophylactic cranial irradiation reduce the incidence of brain metastases in extensive small-cell lung cancer?

N. Choi, L. Halasz, 2008, Nature Clinical Practice Oncology.

Reassessment of loco-regional failure rate in relation with radiation dose in combined modality approach of multidrug chemotherapy and radiotherapy for limited-stage small-cell lung carcinoma.

N. Choi, R. Carey, 1988, Antibiotics and chemotherapy.

Proton SBRT for Medically Inoperable Stage I NSCLC

K. Westover, M. Engelsman, N. Choi, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radioprotective effect of amifostine in radiation pneumonitis.

N. Choi, 2003, Seminars in oncology.

Radiation dose escalation in limited-stage small-cell lung cancer.

N. Choi, T. Lynch, M. Ancukiewicz, 2003, International journal of radiation oncology, biology, physics.

Radiation dose intensification in limited-stage small-cell lung cancer.

N. Choi, T. Lynch, P. Fidias, 2003, Clinical lung cancer.

Phase 1 study to determine the maximum tolerated dose of radiation in standard fractionated and accelerated twice daily radiation schedules with concurrent chemotherapy for limited stage small cell lung cancer (CALGB 8837)

Michael R. Green, N. Choi, J. Rosenman, 1994 .

Combined modality therapy in small cell lung cancer.

J. Jett, R. Arriagada, A. Gregor, 1994, Lung cancer.

FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.

A. Fischman, N. Choi, T. Lynch, 2002, Lung cancer.

Design of 4D treatment planning target volumes.

Eike Rietzel, George T. Y. Chen, Arthur K. Liu, 2006, International journal of radiation oncology, biology, physics.

Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.

Radhe Mohan, Joe Y. Chang, Daniel Gomez, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prospective study of pulmonary tolerance to radiotherapy or radiotherapy plus multidrug chemotherapy for loco-regional lung carcinoma.

N. Choi, H. Kazemi, D. Kanarek, 1988, Antibiotics and chemotherapy.

Prospective prediction of postradiotherapy pulmonary function with regional pulmonary function data: promise and pitfalls.

N. Choi, 1988, International journal of radiation oncology, biology, physics.

Evaluation of pulmonary function changes by postoperative radiotherapy in patients with lung cancer

N. Choi, H. Kazemi, 1980 .

Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.

R. Mak, N. Choi, C. Willett, 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Effects of interfractional anatomical changes on water-equivalent pathlength in charged-particle radiotherapy of lung cancer.

George T. Y. Chen, N. Choi, S. Mori, 2009, Journal of radiation research.

Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer.

James Shackleford, Harald Paganetti, Stephen Dowdell, 2013, International journal of radiation oncology, biology, physics.

A method of calculating a lung clinical target volume DVH for IMRT with intrafractional motion.

P Zygmanski, J H Kung, G. Chen, 2003, Medical physics.

Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

J. Meyerhardt, R. Bueno, N. Choi, 2016, BMC Cancer.

Quantification of Mediastinal Lymph Node Movement Using 4D CT Scan: Implications for Radiation Treatment Planning

A. Niemierko, N. Choi, D. Sher, 2005 .

Bayesian randomized trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer.

Radhe Mohan, Daniel Gomez, James D. Cox, 2016 .

Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.

S. Digumarthy, R. Mak, L. Sequist, 2011, The oncologist.

Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning.

A. Niemierko, N. Choi, D. Sher, 2007, International journal of radiation oncology, biology, physics.

Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.

S. Digumarthy, R. Mak, L. Sequist, 2011 .

Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.

N. Harris, N. Choi, L. Quintanilla‐Martinez, 1996, Human pathology.

Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer.

Steve B. Jiang, H. Shih, N. Choi, 2004, International journal of radiation oncology, biology, physics.

The role of radiotherapy in the management of invasive thymoma

N. Choi, D. Mathisen, M. Sobczak, 1990 .

LOCO—regional failure rate in relation with radiation dose in combined modality approach of multiagent chemotherapy and radiotherapy for limited stage small-cell lung carcinoma

N. Choi, R. Carey, 1987 .